ligands acting on targets

2′,3′-Di-O-acetyladenosine.

2′,3′-Di-O-acetyladenosine.

2′,3′-Dichloro-2,2,2-trimethylacetanilide.

2′,3′-Dichloro-2,2,2-trimethylacetanilide.

2′,3′-Dideoxy-3′-fluoro-a-uridine.

2′,3′-Dideoxy-3′-fluoro-a-uridine.

Shown to be an inhibitor of chain elongation usually catalyzed by DNA polymerase I.

Shown to be an inhibitor of chain elongation usually catalyzed by DNA polymerase I.

Application2',3'-Dideoxycytidine in cells, it is phosphorylated to the active triphosphate form, ddCTP, which acts as a substrate for HIV reverse transcriptase (Ki = 51 nM). It incorporates into viral DNA where it terminates chain elongation when

Application2',3'-Dideoxycytidine in cells, it is phosphorylated to the active triphosphate form, ddCTP, which acts as a substrate for HIV reverse transcriptase (Ki = 51 nM). It incorporates into viral DNA where it terminates chain elongation when

Application2',3'-Dideoxycytidine in cells, it is phosphorylated to the active triphosphate form, ddCTP, which acts as a substrate for HIV reverse transcriptase (Ki = 51 nM). It incorporates into viral DNA where it terminates chain elongation when

2′,3′-Dideoxycytidine 5′-triphosphate sodium salt.